(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of -0.2% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.18%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.93%.
Neogen's revenue in 2026 is $870,539,000.On average, 7 Wall Street analysts forecast NEOG's revenue for 2027 to be $188,644,164,252, with the lowest NEOG revenue forecast at $172,619,074,974, and the highest NEOG revenue forecast at $199,281,845,766. On average, 6 Wall Street analysts forecast NEOG's revenue for 2028 to be $187,372,953,693, with the lowest NEOG revenue forecast at $167,882,509,602, and the highest NEOG revenue forecast at $204,505,998,750.
In 2029, NEOG is forecast to generate $179,641,207,276 in revenue, with the lowest revenue forecast at $172,597,307,670 and the highest revenue forecast at $184,926,308,712.